| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
60,492,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
5,682,564 |
Avg
Vol: |
2,636,078 |
| 52
Week Range: |
$31.96 - $31.96 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Proehl Gerald T |
President & CEO |
• • – |
2013-04-04 |
4 |
OE |
$0.88 |
$75,776 |
D/D |
86,601 |
544,308 |
|
- |
|
| Ballard E David Ii |
SVP, Med Affairs & Pharmvig |
• – – |
2013-04-02 |
4 |
AS |
$17.89 |
$322,092 |
D/D |
(18,000) |
0 |
|
- |
|
| Ballard E David Ii |
SVP, Med Affairs & Pharmvig |
• – – |
2013-04-02 |
4 |
OE |
$1.18 |
$21,240 |
D/D |
18,000 |
18,000 |
|
- |
|
| Burgess Daniel D |
Director |
– • – |
2013-04-01 |
4 |
AS |
$17.47 |
$139,774 |
D/D |
(8,000) |
0 |
|
- |
|
| Burgess Daniel D |
Director |
– • – |
2013-04-01 |
4 |
OE |
$1.18 |
$16,720 |
D/D |
8,000 |
8,000 |
|
- |
|
| Denby William C |
Sr. VP, Commercial Operations |
• – – |
2013-04-01 |
4 |
AS |
$17.75 |
$433,995 |
D/D |
(24,450) |
4,852 |
|
- |
|
| Denby William C |
Sr. VP, Commercial Operations |
• – – |
2013-04-01 |
4 |
OE |
$0.88 |
$2,665 |
D/D |
3,046 |
29,302 |
|
- |
|
| Crawford Debra P |
Sr. VP, CFO, Secy, Treas |
• – – |
2013-03-11 |
4 |
AS |
$15.44 |
$293,373 |
D/D |
(19,000) |
165,964 |
|
- |
|
| Crawford Debra P |
Sr. VP, CFO, Secy, Treas |
• – – |
2013-03-11 |
4 |
OE |
$3.50 |
$66,500 |
D/D |
19,000 |
184,964 |
|
- |
|
| De Meules Julie A |
Sr. VP, Human Resources |
• – – |
2013-03-11 |
4 |
AS |
$15.38 |
$233,169 |
D/D |
(15,165) |
4,948 |
|
- |
|
| De Meules Julie A |
Sr. VP, Human Resources |
• – – |
2013-03-11 |
4 |
OE |
$5.25 |
$79,616 |
D/D |
15,165 |
20,113 |
|
- |
|
| Bedoya-Toro Maria E |
SVP, Regulatory Affairs & QA |
• – – |
2013-03-08 |
4 |
AS |
$15.47 |
$154,699 |
D/D |
(10,000) |
5,849 |
|
- |
|
| Bedoya-Toro Maria E |
SVP, Regulatory Affairs & QA |
• – – |
2013-03-08 |
4 |
OE |
$1.18 |
$11,800 |
D/D |
10,000 |
15,849 |
|
- |
|
| Carter Michael G |
Director |
– • – |
2013-03-07 |
4 |
S |
$15.22 |
$487,040 |
D/D |
(32,000) |
0 |
|
- |
|
| Fox Carey J |
Sr VP, General Counsel |
• – – |
2013-03-07 |
4 |
AS |
$15.25 |
$260,739 |
D/D |
(17,100) |
24,134 |
|
- |
|
| Fox Carey J |
Sr VP, General Counsel |
• – – |
2013-03-07 |
4 |
OE |
$1.18 |
$24,354 |
D/D |
17,100 |
41,234 |
|
- |
|
| Herman Michael E |
Director |
– • – |
2013-03-07 |
4 |
S |
$15.16 |
$687,042 |
I/I |
(45,000) |
16,000 |
|
- |
|
| Herman Michael E |
Director |
– • – |
2013-03-07 |
4 |
OE |
$3.00 |
$128,250 |
I/I |
40,000 |
115,000 |
|
- |
|
| Step Michael D |
SVP, Corporate Development |
• – – |
2013-03-05 |
4 |
AS |
$15.45 |
$468,099 |
D/D |
(30,301) |
1,497 |
|
- |
|
| Step Michael D |
SVP, Corporate Development |
• – – |
2013-03-05 |
4 |
OE |
$1.18 |
$10,560 |
D/D |
8,949 |
31,798 |
|
- |
|
| Proehl Gerald T |
President & CEO |
• • – |
2013-03-04 |
4 |
AS |
$13.57 |
$1,174,803 |
D/D |
(86,601) |
457,707 |
|
- |
|
| Proehl Gerald T |
President & CEO |
• • – |
2013-03-04 |
4 |
OE |
$0.88 |
$75,776 |
D/D |
86,601 |
544,308 |
|
- |
|
| Ballard E David Ii |
SVP, Med Affairs & Pharmvig |
• – – |
2013-03-04 |
4 |
AS |
$13.58 |
$244,481 |
D/D |
(18,000) |
0 |
|
- |
|
| Ballard E David Ii |
SVP, Med Affairs & Pharmvig |
• – – |
2013-03-04 |
4 |
OE |
$1.18 |
$21,240 |
D/D |
18,000 |
18,000 |
|
- |
|
| Hall Warren E |
Sr. VP, Mfg. & Prod. Dev. |
• – – |
2013-03-04 |
4 |
AS |
$13.57 |
$390,069 |
D/D |
(28,749) |
10,546 |
|
- |
|
417 Records found
|
|
Page 8 of 17 |
|
|
